Skip to main content

Lapse in Appropriations

Please note that a lapse in appropriations has caused GAO to shut down its operations. Therefore, GAO will not be able to publish reports or otherwise update this website until GAO resumes operations. In addition, the vast majority of GAO personnel are not permitted to work. Consequently, calls or emails to agency personnel may not be returned until GAO resumes operations. For details on how the bid protest process will be handled during the shutdown, please see the legal decisions page. For information related to the GAO Personnel Appeals Board (PAB), please see the PAB webpage.

Military Health Care

The Defense Health Agency (DHA) uses its clinical adverse action process to investigate concerns about a health care provider's quality of care, and if warranted, to take action to limit or prohibit the care a provider is allowed to deliver. GAO reviewed 55 clinical adverse action cases at four selected military medical treatment facilities and found that they did not always adhere to certain requirements.

For example, in more than one-third of the cases, the facilities did not adhere to the DHA requirement to establish a deadline for the investigation of a provider. GAO also found that DHA did not always report providers within required time frames. GAO is making six recommendations, including for DHA to improve its monitoring approach and establish timeliness requirements for steps in the clinical adverse action process.
Date: Apr 11, 2024
Runtime: 00:01:06
Learn more
Military Health Care: DOD Should Improve Its Process for Clinical Adverse Actions against Providers
Privacy Statement

This player is provided by Google/YouTube, which may set a persistent cookie on your computer or device upon its use. Consult YouTube's privacy policies for further information. Please see GAO's Privacy, Legal and Other Site Policies for information about GAO's privacy policy.